Skip to main content

Table 2 Laboratory characteristics of patients at baseline and after three-month rosuvastatin therapy

From: Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment

        Diabetic patients (n = 10)       Hypercholesterolemic patients (n = 10)
baseline treatment #P baseline treatment #P
TC (mg/dl) 223.7 ± 34.0 168.5 ± 45.9 0.003 288.2 ± 41.0 165.5 ± 24.4 <0.001
TG (mg/dl) 165.3 ± 73.0 118.5 ± 31.5 0.012 180.9 ± 61.4 133.5 ± 58.9 0.004
HDL-c (mg/dl) 50.0 ± 2.8 50.2 ± 6.5 0.94 55.1 ± 9.9 50.7 ± 12.1 0.164
LDL-c (mg/dl) 135.7 ± 20.6 85.0 ± 25.6 <0.001 197.0 ± 34.1 88.1 ± 25.1 <0.001
ApoA (mg/dl) 128.0 ± 53.0 163.0 ± 14.4 0.69 144.5 ± 28.5 160.1 ± 55.4 0.34
ApoB (mg/dl) 117.2 ± 29.1 54.0 ± 14.9 <0.001 147.1 ± 38.8 75.1 ± 24.6 <0.001
Glucose (mg/dl) 137.7 ± 19.4 135.5 ± 31.8 0.79 98.6 ± 5.7 97.0 ± 12.9 0.77
Insulinemia (ng/ml) 14.2 ± 3.4 16.3 ± 3.5 0.63 18.8 ± 14.7 19.7 ± 17.0 0.63
AST 24.2 ± 4.3 24.0 ± 4.1 0.94 18.3 ± 5.6 17.1 ± 3.5 0.658
ALT 37.7 ± 19.2 39.2 ± 27.1 0.78 27.6 ± 12.9 21.3 ± 4.4 0.122
GGT 43.3 ± 27.2 46.5 ± 39.6 0.65 21.7 ± 5.9 20.1 ± 5.6 0.131
CK 226.8 ±113.7 212.7 ± 103.5 0.73 135.7 ± 64.9 134.4 ± 56.6 0.994
s-creatinine 0.98 ± 0.11 0.97 ± 0.10 0.89 0.98 ± 0.17 0.99 ± 0.18 0.597
GFR 76.33 ± 12.18 77.5 ± 3.56 0.79 73.22 ± 33.31 74.00 ± 12.09 0.667
hsCRP 2.94 ± 2.02 1.76 ± 0.51 0.03 1.70 ± 1.69 1.15 ± 0.79 0.350
  1. TC = total cholesterol; TG = triglycerides; HDL-c = high density lipoprotein-cholesterol; LDL-c = low density lipoprotein-cholesterol; ApoA = Apolipoprotein A; ApoB = Apolipoprotein B; AST = aspartate aminotransferase; ALT = alanine aminotransferase; GGT = γ-glutamyl transpeptidase; CK = creatine kinase; GFR = glomerular filtration rate; hsCRP = high sensitivity C reactive protein. # Paired t test.